Characterizing Clinician Communication with Patients about Lecanemab: A Qualitative Study of Clinicians across Seven Academic Medical Centers
Clinicians at the forefront of lecanemab treatment use a variety of communication approaches to discuss benefits and risks. These insights can guide future interventions to improve communication and decision-making for lecanemab.
Authors
- Anna L. Parks (ORCID: https://orcid.org/0000-0003-1377-5406)
- Kim G. Johnson (ORCID: https://orcid.org/0000-0002-8793-2489)
- Joanna Paladino (ORCID: https://orcid.org/0000-0001-9324-1943)
- Daniel Dohan (ORCID: https://orcid.org/0000-0002-7052-1288)
- Ayush Thacker
- Sachin J Shah
- Christine S Ritchie
- Liliana A Ramirez Gomez
Institutions
- Harvard University (US)
- Duke University (US)
- University of California, San Francisco (US)
- University of Utah (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70858_096332
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00